Welcome ACCORDANCE study from Intec!

Welcome Intec Pharma, currently conducting the Phase III ACCORDANCE study of the carbidopa/ levodopa “Accordion Pill.”

Moving Day has raised over $35 million and brought more than 161,600 participants together.